Clinical trial
Green Tea Extract in Preventing Cervical Cancer in Patients With Human…
NCT00303823 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00303823 |
|---|---|
| Title | Green Tea Extract in Preventing Cervical Cancer in Patients With Human Papillomavirus and Low-Grade Cervical Intraepithelial Neoplasia |
| Official title | A Phase II Trial of Polyphenon E for Cervical Cancer Prevention |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cervical Cancer, Cervical Intraepithelial Neoplasia Grade 1, Human Papilloma Virus Infection |
| Intervention type | Dietary Supplement, Drug, Other |
| Interventions | placebo, defined green tea catechin extract, laboratory biomarker analysis |
| Enrollment | 98 |
| Start date | Sep 1, 2005 |
| Primary completion | Nov 1, 2010 |
| Completion | Feb 1, 2011 |
| First posted | Mar 17, 2006 |
| Last update posted | May 5, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: